Pulmonary Embolism in Patients Admitted With Takotsubo Cardiomyopathy: Prevalence and Associated In-Hospital Adverse Events.

ABSTRACT

Introduction  Takotsubo cardiomyopathy (TCM) is a poorly understood condition typically characterized by abnormal left ventricular wall motion without causative coronary artery disease and typically presents in post-menopausal women after the experience of a physical or emotional stressor. The pathophysiology of TCM is complex and multifactorial, resulting in complications with varied severity; one of the most concerning complications is thromboembolism, specifically, pulmonary embolism (PE), which is understudied in its relation to TCM. The purpose of this study was to characterize and evaluate the real-world prevalence and outcomes of PE in TCM. Methods  Data were derived from the National Inpatient Sample database from January 2016 to December 2019. The primary outcomes assessed were baseline and hospital admission characteristics and comorbidities for patients with TCM with and without PE. Outcomes for TCM patients with PE and predictors of mortality in TCM were also analyzed. Results  PE developed in 788 of 40,120 patients with TCM (1.96%). After multivariate adjustment, PE was found to be independently associated with intracardiac thrombus (adjusted odds ratio (aOR) 2.067; 95% confidence interval (CI) 1.198-3.566; p = 0.009) and right heart catheterization (RHC) (aOR 1.971; 95% CI 1.160-3.350; p = 0.012). Mortality in patients with TCM was associated with, among other factors, age in years at admission (aOR 1.104; 95% CI 1.010-1.017; p = 0.001), African American race (aOR 1.191; 95% CI 1.020-1.391; p = 0.027), Asian or Pacific Islander race (aOR 1.637; 95% CI 1.283-2.090; p = 0.001), coagulopathy (aOR 3.393; 95% CI 2.889-2.986; p = 0.001), liver disease (aOR 1.446; 95% CI 1.147-1.824; p = 0.002), atrial fibrillation (aOR 1.460; 95% CI 1.320-1.615; p = 0.001), and pulmonary embolism (aOR 2.217; 95% CI 1.781-2.760; p = 0.001). Conclusion  In a large cohort of patients admitted with TCM, we found the prevalence of PE to be 1.96%. PE, along with comorbidities such as coagulopathy and atrial fibrillation, was found to be a significant predictor of mortality in this patient cohort.